Cantor Fitzgerald Reaffirms Neutral Rating for Acadia Healthcare (NASDAQ:ACHC)

Cantor Fitzgerald reaffirmed their neutral rating on shares of Acadia Healthcare (NASDAQ:ACHC) in a research note issued to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $90.00 target price on the stock.

A number of other analysts have also recently issued reports on ACHC. Mizuho lowered their price objective on Acadia Healthcare from $84.00 to $70.00 and set a neutral rating on the stock in a research report on Friday, May 3rd. Barclays lowered their price target on shares of Acadia Healthcare from $91.00 to $89.00 and set an overweight rating on the stock in a report on Wednesday, May 15th. Bank of America reduced their price objective on shares of Acadia Healthcare from $105.00 to $90.00 and set a buy rating for the company in a report on Thursday, May 2nd. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a sell rating to a hold rating and set a $70.00 target price on the stock in a research note on Thursday, April 25th. Finally, StockNews.com downgraded Acadia Healthcare from a hold rating to a sell rating in a report on Tuesday, May 21st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of Moderate Buy and an average price target of $87.56.

Acadia Healthcare Trading Up 0.1 %

NASDAQ:ACHC opened at $67.19 on Tuesday. The firm has a market cap of $6.23 billion, a price-to-earnings ratio of -479.89, a P/E/G ratio of 1.92 and a beta of 1.31. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.63. Acadia Healthcare has a 12 month low of $62.04 and a 12 month high of $87.77. The company’s 50 day moving average is $67.41 and its 200-day moving average is $75.14.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. The company had revenue of $768.10 million during the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. Acadia Healthcare’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same period in the prior year, the business earned $0.75 earnings per share. Equities analysts anticipate that Acadia Healthcare will post 3.52 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. Vaughan Nelson Investment Management L.P. bought a new stake in shares of Acadia Healthcare during the fourth quarter worth $24,157,000. Louisiana State Employees Retirement System bought a new stake in Acadia Healthcare during the 4th quarter worth about $2,014,000. Rhenman & Partners Asset Management AB bought a new stake in Acadia Healthcare during the 4th quarter worth about $1,448,000. Phocas Financial Corp. bought a new position in shares of Acadia Healthcare in the fourth quarter worth about $6,887,000. Finally, Sivik Global Healthcare LLC lifted its position in shares of Acadia Healthcare by 20.0% during the fourth quarter. Sivik Global Healthcare LLC now owns 90,000 shares of the company’s stock worth $6,998,000 after purchasing an additional 15,000 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.